Current topics in medicinal chemistry最新文献

筛选
英文 中文
Biogenic Synthesis of Pure, Moxifloxacin- and Quercetin-Functionalized Zinc Oxide Nanoparticles and Investigation of Their In-Vitro Antioxidant and Antibacterial Activities. 莫西沙星和槲皮素功能化氧化锌纳米粒子的生物合成及其体外抗氧化和抗菌活性研究。
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-11-10 DOI: 10.2174/0115680266511354261104065347
Anjali Suryavanshi, Dishen Kumar, Dileep Kumar, Sanjay Kumar Bharti
{"title":"Biogenic Synthesis of Pure, Moxifloxacin- and Quercetin-Functionalized Zinc Oxide Nanoparticles and Investigation of Their <i>In-Vitro</i> Antioxidant and Antibacterial Activities.","authors":"Anjali Suryavanshi, Dishen Kumar, Dileep Kumar, Sanjay Kumar Bharti","doi":"10.2174/0115680266511354261104065347","DOIUrl":"https://doi.org/10.2174/0115680266511354261104065347","url":null,"abstract":"<p><strong>Introduction: </strong>Zinc oxide nanoparticles (ZnO-NPs) are widely studied due to their stability, low toxicity, and strong antimicrobial properties. Green synthesis using plant extracts offers an eco-friendly and cost-effective approach. This study focuses on the biogenic synthesis of ZnO-NPs functionalized with moxifloxacin and quercetin to enhance antioxidant and antibacterial activities.</p><p><strong>Materials and methods: </strong>ZnO nanoparticles were synthesized using Hygrophila auriculata leaf extract via a green synthesis method. Moxifloxacin- and quercetin-loaded ZnO-NPs were prepared through functionalization. Characterization was performed using UV-Vis spectroscopy, XRD, FTIR, DLS, SEM, TEM, and EDX. Antioxidant activity was evaluated by DPPH radical scavenging assay, while antibacterial activity was assessed using agar well diffusion against E. coli, S. aureus, and P. aeruginosa.</p><p><strong>Results: </strong>UV-Vis confirmed ZnO nanoparticle formation with an absorption peak around 364 nm. DLS analysis showed stable nanoparticles (~125 nm, -21.5 mV). XRD and SAED confirmed a crystalline hexagonal structure with sizes ~10-12 nm. SEM/TEM revealed spherical and mixed morphologies. Quercetin-loaded ZnO-NPs exhibited the highest antioxidant activity (≈86% at 1600 μg/mL). Moxifloxacin-functionalized ZnO-NPs demonstrated superior antibacterial activity, with maximum zones of inhibition (16 mm for E. coli, 15 mm for S. aureus).</p><p><strong>Discussion: </strong>Phytochemicals served as stabilising and reducing agents during synthesis. Functionalization enhanced biological performance, with quercetin improving antioxidant potential and moxifloxacin providing synergistic antibacterial effects. Structural and surface modifications contributed to improved activity.</p><p><strong>Conclusion: </strong>Biogenic synthesis of functionalized ZnO nanoparticles resulted in formulations exhibiting antioxidant and antibacterial activities. Among the tested formulations, moxifloxacinloaded ZnO nanoparticles demonstrated the highest antibacterial activity against the evaluated bacterial strains. These findings demonstrate their in vitro antibacterial potential. However, further studies involving cytotoxicity, drug-release kinetics, mechanistic investigations, and in vivo validation are required to establish their therapeutic applicability.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Product-Derived Antimicrobials: Emerging Strategies to Combat Antimicrobial Resistance. 天然产物衍生抗菌素:对抗抗菌素耐药性的新策略。
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-11-06 DOI: 10.2174/0115680266526376261102111901
Ajay Kumar, Abinash Chand Bharati, Gazala Parveen, Rinkesh Chaudhary, Israr Ansari
{"title":"Natural Product-Derived Antimicrobials: Emerging Strategies to Combat Antimicrobial Resistance.","authors":"Ajay Kumar, Abinash Chand Bharati, Gazala Parveen, Rinkesh Chaudhary, Israr Ansari","doi":"10.2174/0115680266526376261102111901","DOIUrl":"https://doi.org/10.2174/0115680266526376261102111901","url":null,"abstract":"<p><p>Antimicrobial agents are the mainstay of therapeutic intervention against bacterial pathogens, which have bactericidal or bacteriostatic effects by disrupting key cellular functions. Nevertheless, the development and spread of antimicrobial resistance worldwide has become a severe social health crisis, making traditional treatment methods less effective against multidrugresistant organisms. The phenomenon of resistance is the driving force behind the pressing need to find new antimicrobial scaffolds that can circumvent existing resistance mechanisms. Natural products have historically been a source of antimicrobial agents, serving as the basis for many clinically effective antibiotics in modern medicine. Modern research efforts are investigating diverse biological sources, such as phytochemicals from medicinal plants, essential oils rich in bioactive terpenoids and phenolic compounds, antimicrobial peptides with membrane-disrupting activity, and synthetic-optimized traditional antibiotics. Moreover, metallic nanoparticles, including silver and gold, show potential antimicrobial activity at nanoscale concentrations, representing novel therapeutic modalities. Secondary metabolites from bacteria and fungi continue to yield structurally diverse compounds with strong antimicrobial activity against pesticide-resistant agricultural pathogens. All these new therapeutic platforms show significant potential to overcome evolved resistance mechanisms through new mechanisms of action, new cellular targets, and improved bioavailability profiles. The existing evidence suggests that naturally derived compounds, rationally designed and developed with nanotechnology-based delivery systems, can be used to restore antimicrobial activity against otherwise drug-resistant pathogens. This approach to natural product-based antimicrobial discovery is a strategy for the discovery and development of antimicrobial candidates that can help tackle the current global antimicrobial resistance crisis.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discovery and Development of Nitrophenyl-Imidazolidine-Benzoate- Centred Chemotypes for Contemporary Antimicrobial Therapy. 以硝基苯-咪唑烷-苯甲酸酯为中心的现代抗菌药物化学型的发现和发展。
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-11-05 DOI: 10.2174/0115680266495392261029094534
Manikandan Sankaran, Manikandan Alagumuthu, Kiruthiga Kaliyamoorthy
{"title":"Discovery and Development of Nitrophenyl-Imidazolidine-Benzoate- Centred Chemotypes for Contemporary Antimicrobial Therapy.","authors":"Manikandan Sankaran, Manikandan Alagumuthu, Kiruthiga Kaliyamoorthy","doi":"10.2174/0115680266495392261029094534","DOIUrl":"https://doi.org/10.2174/0115680266495392261029094534","url":null,"abstract":"<p><strong>Introduction: </strong>The escalation of antimicrobial resistance is prompting the search for new antimicrobials with greater potency and broad-spectrum efficacy. This study synthesised a targeted library of Nitrophenyl-Imidazolidine-Benzoate (NIB) derivatives (5a-l) by altering the imidazolidine-2,4-dione core at the N-1, N-3, and C-5 positions to assess their antimicrobial properties.</p><p><strong>Method: </strong>Synthesis of molecules (5a- l), screening them through molecular docking validated by MD simulations, and then conducting antimicrobial and cytotoxicity studies.</p><p><strong>Results: </strong>Several derivatives showed moderate to good activity, with minimum inhibitory concentrations (MICs) ranging from 0.2 to 15 μg/mL against Gram-positive organisms and from 0.15 to 10 μg/mL against Gram-negative organisms. The C-5 para-chloro-phenyl compound was the most active, with MICs of 4 μg/mL (S. aureus) and 8 μg/mL (E. coli), nearly equal to those of the reference antibiotic ciprofloxacin. Heteroaryl groups at N-1 and small alkyl groups at N-3 were found to be favourable in terms of membrane permeability and to have balanced lipophilicity (logP 2.4-3.8), which was seen to be correlated with the improved potency.</p><p><strong>Discussion: </strong>Investigating the structure-activity relationship (SAR), it was found that the presence of halogenated aryl groups at C-5 and electron-donating substituents on the aromatic ring led to a significant increase in activity, whereas the application of too much steric bulk had the opposite effect of reducing efficacy.</p><p><strong>Conclusion: </strong>In conclusion, the research indicates that Nitrophenyl-Imidazolidine-Benzoate (NIB) derivatives are a strong and flexible scaffold for the development of antimicrobial agents, at the same time offering clear SAR and spotting candidates that are worth further optimisation.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting HTLV-1 Tax: Towards a Therapeutic Strategy for HTLV-1- Associated Diseases. 靶向HTLV-1: HTLV-1相关疾病的治疗策略。
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-10-30 DOI: 10.2174/0115680266448515261028095459
Sudipto Roy, Sayak Sanyal, Manish Dwivedi, Somali Sanyal
{"title":"Targeting HTLV-1 Tax: Towards a Therapeutic Strategy for HTLV-1- Associated Diseases.","authors":"Sudipto Roy, Sayak Sanyal, Manish Dwivedi, Somali Sanyal","doi":"10.2174/0115680266448515261028095459","DOIUrl":"https://doi.org/10.2174/0115680266448515261028095459","url":null,"abstract":"<p><p>Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that belongs to the family Retroviridae and the genus Deltaretrovirus. HTLV-1 infection is linked to acute and chronic illnesses, including adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other inflammatory disorders. This overview focuses on the molecular biology of HTLV-1, with particular emphasis on viral structure and genome organization, as well as the roles of key viral proteins in replication and pathogenesis. Special attention is given to the viral regulatory proteins Tax and HTLV-1 basic leucine zipper factor (HBZ), which drive cellular transformation, immune dysregulation, viral persistence, and disease progression. This review examines the oncogenic role of the Tax protein and its potential contribution to the immunopathogenesis of HAM/TSP. Furthermore, it summarizes current and novel therapeutic strategies against HTLV-1-associated diseases, focusing on antiretroviral therapy, immunomodulatory approaches, and Tax-targeted therapies. Challenges in clinical translation and limitations of current treatments are also discussed. This review covers most facets of HTLV-1 biology, pathogenesis, and treatment strategies, with the overall message that more studies are warranted for effective targeted therapies and disease management.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-Engineered Immune Cells as Programmable Living Therapeutics: Cell Sources, Engineering Routes, and Translational Bottlenecks. car工程免疫细胞作为可编程的活疗法:细胞来源、工程路线和转化瓶颈。
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-10-28 DOI: 10.2174/0115680266534378261027112811
Xinyuan Cao, Aiming Yang
{"title":"CAR-Engineered Immune Cells as Programmable Living Therapeutics: Cell Sources, Engineering Routes, and Translational Bottlenecks.","authors":"Xinyuan Cao, Aiming Yang","doi":"10.2174/0115680266534378261027112811","DOIUrl":"https://doi.org/10.2174/0115680266534378261027112811","url":null,"abstract":"<p><p>Chimeric Antigen Receptor (CAR)-engineered immune cells now extend well beyond autologous CAR-T therapy to span early-clinical NK, invariant natural killer T, gamma-delta T, and double-negative T platforms, clinical-stage regulatory T-cell programs, preclinical macrophage, neutrophil and dendritic-cell systems, and adjacent BCR/antibody-engineered B-cell approaches. This Perspective proposes a chassis-aware framework in which target biology and tissue location determine the required effector function, and this function in turn constrains cell source, receptor architecture and antigen logic, engineering route, developability assays, and safety controls, rather than allowing receptor design to be transferred unchanged from the CD19 CAR-T precedent. Each chassis requires a lineage-adapted signalling architecture, and ex vivo and in vivo programming are treated as distinct pharmacological strategies with different implications for expression duration, biodistribution, off-target transduction, redosing, and rescue. Clinical translation further requires chassis- and route-specific potency assays, predefined critical quality attributes, batch comparability, quantitative biodistribution and persistence measurements, and controls for lineage instability or suppressive polarization. Treating each chassis-route combination as a distinct therapeutic hypothesis, rather than a variant of CAR-T, provides a testable and generalizable route from molecular design to clinical and regulatory development.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structure-Activity Relationships and Mechanisms of Antitumor Activities of Quinoline Derivatives: A Review. 喹啉衍生物的构效关系及抗肿瘤作用机制研究进展
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-10-28 DOI: 10.2174/0115680266525818261023120040
Hua-Peng Liu, ZhenChao Hu, TaoFeng Zhang, Xi-Cun Wang
{"title":"Structure-Activity Relationships and Mechanisms of Antitumor Activities of Quinoline Derivatives: A Review.","authors":"Hua-Peng Liu, ZhenChao Hu, TaoFeng Zhang, Xi-Cun Wang","doi":"10.2174/0115680266525818261023120040","DOIUrl":"https://doi.org/10.2174/0115680266525818261023120040","url":null,"abstract":"<p><p>The persistent threat posed by cancer and the emergence of chemoresistance necessitate the development of novel therapeutics, positioning quinoline derivatives as privileged scaffolds in oncology. This review systematically consolidates recent advances (2019-2025) in Structure- Activity Relationships (SARs) and molecular mechanisms governing the antitumor efficacy of quinoline-based compounds. We focus on structure-activity relationship analysis of kinase inhibitors (targeting EGFR, MEK1, etc.), topoisomerase inhibitors, Tubulin Polymerization Inhibitors, mitochondrial/lysosomal targeting agents (inducing oxidative stress and organelle damage), and DNA-damaging agents (metal ligands or those causing DNA breaks). Structure-activity relationship studies indicate that the structural modification strategies corresponding to different mechanisms vary significantly, and the position of substituents, electronic effects, and scaffold transitions are crucial for drug efficacy. This review provides a rational blueprint for designing next-generation anticancer agents with enhanced efficacy and reduced systemic toxicity, thereby accelerating future drug development.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AMPK-PPARα-CD36 Axis Mediates Berberine's Amelioration of Olanzapine-Induced Lipid Dysregulation in Mice. AMPK-PPARα-CD36轴介导小檗碱改善奥氮平诱导的小鼠脂质失调。
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-10-26 DOI: 10.2174/0115680266501840260908094307
Mengyuan Yang, Mei Li, Didi Yuan, Renkuan Tang
{"title":"AMPK-PPARα-CD36 Axis Mediates Berberine's Amelioration of Olanzapine-Induced Lipid Dysregulation in Mice.","authors":"Mengyuan Yang, Mei Li, Didi Yuan, Renkuan Tang","doi":"10.2174/0115680266501840260908094307","DOIUrl":"https://doi.org/10.2174/0115680266501840260908094307","url":null,"abstract":"<p><strong>Introduction: </strong>While olanzapine is an effective atypical antipsychotic, its clinical application is limited by adverse effects such as weight gain and lipid metabolism disorders. Berberine, a natural compound known for its lipid-lowering and anti-inflammatory properties, presents a potential therapeutic strategy to counteract these issues. Therefore, this study aimed to explore the ameliorative impact of berberine on olanzapine-induced lipid metabolism disorders in mice, with a specific focus on the AMPK-PPARα-CD36 signaling axis.</p><p><strong>Methods: </strong>Male C57 mice were divided into control, olanzapine, and olanzapine + berberine groups, treated for 6 weeks. Plasma TG, TC, HDL-C, and LDL-C were measured. Liver tissues were stained for lipid accumulation. Hub genes were identified through PubMed searches, differential analysis, weighted gene co-expression network analysis, and SVM-RFE. Protein expressions of AMPK, p-AMPK, PPARα, and CD36 were assessed by Western blot.</p><p><strong>Results: </strong>Olanzapine increased plasma TG and HDL-C, decreased TC and LDL-C, and caused hepatic lipid accumulation. It also downregulated AMPK/p-AMPK and PPARα, while upregulating CD36. Berberine reversed these effects, lowering TG, partially restoring TC and LDL-C, reducing liver lipid deposition, increasing AMPK/p-AMPK and PPARα, and inhibiting CD36 expression.</p><p><strong>Discussion: </strong>Olanzapine-induced lipid dysregulation may be mediated by the inhibition of AMPK and PPARα and the upregulation of CD36. Berberine effectively reversed these changes by activating the AMPK-PPARα pathway and inhibiting CD36 expression, thereby improving hepatic lipid accumulation. These findings suggest that berberine may serve as a potential adjunctive therapy for alleviating olanzapine-induced metabolic side effects.</p><p><strong>Conclusion: </strong>Olanzapine induces lipid disorders by inhibiting AMPK, reducing PPARα, and upregulating CD36, enhancing lipid uptake and impairing fatty acid oxidation. Berberine ameliorates these abnormalities by activating AMPK-PPARα signaling and suppressing CD36, highlighting its potential as an adjunctive therapy to mitigate olanzapine-induced metabolic side effects.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating AI-Based De Novo Design with Molecular Docking and Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as p53-MDM2 Inhibitors for Triple-Negative Breast Cancer. 基于人工智能的从头设计、分子对接和密度泛函数理论分析优化类黄酮支架p53-MDM2抑制剂治疗三阴性乳腺癌
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-10-26 DOI: 10.2174/0115680266474465260825060836
Dwi Syah Fitra Ramadhan, Regina Dwi Putri Mahardika, Muli Sukmawaty, Kay Khine Soe, Tee Yee Sim, Hooi Chia Tang, Hana Chen
{"title":"Integrating AI-Based De Novo Design with Molecular Docking and Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as p53-MDM2 Inhibitors for Triple-Negative Breast Cancer.","authors":"Dwi Syah Fitra Ramadhan, Regina Dwi Putri Mahardika, Muli Sukmawaty, Kay Khine Soe, Tee Yee Sim, Hooi Chia Tang, Hana Chen","doi":"10.2174/0115680266474465260825060836","DOIUrl":"https://doi.org/10.2174/0115680266474465260825060836","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;An important regulatory aspect of cancer progression is the interaction between p53 and MDM2, particularly in breast cancer, where the excessive presence of MDM2 hampers p53's tumour- suppressing function. Although many natural flavonoids are recognized for their influence on this pathway, they often exhibit suboptimal potency and pharmacokinetic properties. To discover flavonoid derivatives with stronger inhibitory effects on the p53-MDM2 interaction, this research integrates Density Functional Theory (DFT), molecular docking, and AI-enhanced de novo optimization.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;Validated molecular docking protocols were employed to evaluate 52 flavonoids from the Indonesian Natural Products Database against the p53-MDM2 complex, yielding a validation RMSD value of 0.4935 Å. AI-assisted molecular design was subsequently applied to the top-performing compounds to generate optimized derivatives with improved binding affinity and pharmacokinetic properties. Binding interactions were analyzed using conventional molecular visualization approaches. Drug-likeness, ADME, and toxicity profiles were predicted using SwissADME, ProTox-II, and ADMETlab 2.0. Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d,p) level were performed to evaluate electronic properties and molecular stability. Furthermore, Molecular Dynamics (MD) simulations and MM-GBSA calculations were conducted to investigate the dynamic stability and binding free energy of the selected complexes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among the AI-optimized derivatives, Amentoflavone-1 demonstrated the strongest binding affinity (-5.60 kcal/mol), outperforming Resveratrol (-4.24 kcal/mol). Interaction profiling revealed that hydrophobic interactions and π-π stacking with key residues within the p53-MDM2 binding pocket were the primary stabilizing forces. ADME predictions indicated improved drug-likeness and absorption properties, while toxicity analyses suggested reduced mutagenicity and mitochondrial toxicity, though a moderate hepatotoxicity risk remained. DFT calculations demonstrated favourable HOMO- LUMO energy gaps and frontier molecular orbital characteristics associated with molecular stability and chemical reactivity. Molecular dynamics simulations over 100 ns showed that the p53-MDM2- Amentoflavone-1 complex maintained a stable conformation comparable to the native ligand, as evidenced by RMSD, RMSF, SASA, and radius-of-gyration analyses. In addition, MM-GBSA calculations revealed a binding free energy of -18.37 kcal/mol for Amentoflavone-1, confirming spontaneous and thermodynamically favourable binding to the p53-MDM2 complex.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;The integration of AI-driven de novo design with conventional computational modelling successfully enhanced and clarified the pharmacological potential of flavonoid scaffolds. Amentoflavone- 1 exhibited favourable binding interactions consistent with k","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventive Effects of Mānuka Honey and a Honey Sugar Analogue on Breast Cancer Development: Modulation of Oxidative Stress and AKT/mTOR Signaling in a Rat Model. Mānuka蜂蜜和蜂蜜糖类似物对乳腺癌发展的预防作用:大鼠模型中氧化应激和AKT/mTOR信号的调节
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-10-22 DOI: 10.2174/0115680266534322261021092711
Manar Usama, Al-Shimaa M Abas, Heba A H Abd Elhameed
{"title":"Preventive Effects of Mānuka Honey and a Honey Sugar Analogue on Breast Cancer Development: Modulation of Oxidative Stress and AKT/mTOR Signaling in a Rat Model.","authors":"Manar Usama, Al-Shimaa M Abas, Heba A H Abd Elhameed","doi":"10.2174/0115680266534322261021092711","DOIUrl":"https://doi.org/10.2174/0115680266534322261021092711","url":null,"abstract":"<p><strong>Introduction: </strong>Worldwide, breast cancer is one of the top cancers diagnosed on a global scale. Mānuka honey (MH) and honey sugar analogue (HSA) are being studied for their potential to prevent breast cancer.</p><p><strong>Materials and methods: </strong>A total of 60 Female albino rats were classified into six groups. Group I (negative control group). Group II (MH): rats were administered MH (1.0 g/kg) daily via an oral tube for 120 days. Group III (HSA): rats were administered HSA (1.0 g/kg) daily via an oral tube for 120 days. Group IV (DMBA): rats were treated with a single dose of DMBA (80 mg/kg) via oral tube to induce breast cancer. Group V (DMBA + MH) & Group VI (DMBA + HSA): rats were treated with MH (1.0 g/kg) and HSA (1.0 g/kg), respectively, via oral tube, then received a single dose of DMBA the next day, and treatment with MH & HSA continued until 120 days.</p><p><strong>Results: </strong>Oral administration of MH and HSA improved most hematological parameters. Additionally, we also found a significant suppression in Estradiol (E2) and a clear decrease in caspase- 3, MDA, and mTOR) values in mammary gland tissue samples compared to DMBA-induced rats. Furthermore, BRCA1 expression was increased in both MH and HSA groups, and a marked downregulation of AKT was observed in our treated groups. Our findings were supported by histopathological examination of mammary gland tissue.</p><p><strong>Discussion: </strong>This study highlights the potential of daily oral administration of MH and HSA to exert antioxidant and antitumor effects and to modulate apoptosis-related signaling pathways in DMBA-induced rats.</p><p><strong>Conclusion: </strong>MH and HSA demonstrated promising chemopreventive and protective effects against DMBA-induced mammary carcinogenesis, warranting further studies to evaluate their potential role in breast cancer prevention.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the Phytopharmacological Potential of Morus alba: Bioactive Constituents, Therapeutic Potential, and Future Prospects. 揭示桑的植物药理学潜力:生物活性成分、治疗潜力和未来展望。
IF 3.6 4区 医学
Current topics in medicinal chemistry Pub Date : 2026-10-16 DOI: 10.2174/0115680266474686260903044801
Akash Bhati, Navneet Sharma, Bharat Bhusan, Praveen Nasa, Deepika Bhatia, Hitesh Kumar Dewangan
{"title":"Unveiling the Phytopharmacological Potential of Morus alba: Bioactive Constituents, Therapeutic Potential, and Future Prospects.","authors":"Akash Bhati, Navneet Sharma, Bharat Bhusan, Praveen Nasa, Deepika Bhatia, Hitesh Kumar Dewangan","doi":"10.2174/0115680266474686260903044801","DOIUrl":"https://doi.org/10.2174/0115680266474686260903044801","url":null,"abstract":"<p><p>Morus alba L., a member of the Moraceae family, is widely recognised for its medicinal and nutritional importance. Various extracts from Traditional Chinese, Ayurvedic, and Korean medicine systems are widely used, including tree leaves, fruits, root bark, and branches. This review critically summarises the pharmacological potential, phytochemical profile, and emerging therapeutic applications of Morus alba L. based on available preclinical and analytical studies. These activities are attributed to diverse bioactive constituents, including stilbenes, anthocyanins, phenolic acids, alkaloids, and flavonoids. Besides, the plant is important in sericulture and offers possible health advantages as a health supplement, herbal tea, jams, oils, and functional foods. This review compiles and evaluates extraction and analytical techniques used for the identification and characterisation of bioactive compounds from Morus alba. These include HPLC, GC-MS, NMR, ethanol-based extraction, hot water extraction, and advanced proteomic and metabolomic approaches. Chemometric tools, along with HPLC-DAD and UHPLC-ESI-MSn, are widely used for quality assessment and chemical standardisation. Recent studies in emerging areas such as molecular docking, ligand fishing, and nanoparticle-based systems further highlight its potential in drug discovery and delivery. Morus alba-mediated nanoparticles have also demonstrated antimicrobial, antioxidant, and drug delivery potential. This review highlights current evidence, identifies research gaps, and provides future directions for the development of Morus alba-based therapeutic and functional applications.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书